Evaluation of Antibiotic Use in Patients Diagnosed With Upper Respiratory Tract Infections at Aur Berduri Health Center, Merangin Regency, Jambi Province, in 2025

Authors

  • Azizah Ulya Harapan Ibu School of Health Sciences, Indonesia
  • Armini Hadriyati Harapan Ibu School of Health Sciences, Indonesia
  • Rizky Nurhikmah Harapan Ibu School of Health Sciences, Indonesia

DOI:

https://doi.org/10.57235/jetish.v5i2.9255

Keywords:

Amoxicillin, Antibiotics, Health Center, Rationality

Abstract

Upper respiratory tract infections are among the most common diseases encountered in healthcare facilities, and irrational use of antibiotics can lead to bacterial resistance and treatment failure. This study aimed to evaluate the rationality of antibiotic use in patients diagnosed with upper respiratory tract infections at Aur Berduri Health Center, Merangin Regency, Jambi Province. This was a non-experimental study using a retrospective method and descriptive analysis. Data were obtained from the medical records of outpatients diagnosed with upper respiratory tract infections who met the inclusion and exclusion criteria, comprising 42 patients aged 1–18 years. Antibiotic use was evaluated based on the parameters of appropriate patient, appropriate indication, appropriate drug, and appropriate dose, referring to pharmaceutical care standards for upper respiratory tract infections. The results showed that there were more male patients than female patients, namely 24 patients (57.14%), and the largest age group was 5–9 years, comprising 16 patients (38.09%). The antibiotic used was amoxicillin, a penicillin-class antibiotic, with a utilization rate of 100%. Evaluation of the rationality of antibiotic use showed 100% appropriate patient, 100% appropriate indication, 100% appropriate drug, and 100% appropriate dose. The conclusion of this study indicates that antibiotic use among patients diagnosed with upper respiratory tract infections at Aur Berduri Health Center met the criteria for rational drug use based on the parameters of appropriate patient, appropriate indication, appropriate drug, and appropriate dose.

Downloads

Download data is not yet available.

References

Dewi, R., Dewi, R., Sutrisno, D., Sutrisno, D., & Medina, F. (2020). Evaluasi Penggunaan Antibiotik Infeksi Saluran Pernapasan Atas pada Anak di Puskesmas Olak Kemang Kota Jambi Tahun 2018. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 17(1), 158. https://doi.org/10.30595/pharmacy.v17i1.6936

Eva Wardah, I. R. (2025). Evaluasi Penggunaan Antibiotik di Masyarakat. 9(2024), 120–128.

Hafni Nur Insan, Rini Fitriani Dongoran, R. A. M. (2022). Jurnal Kesehatan Ilmiah Indonesia (Indonesian Scientific Health Journal): Evaluasi Terapi Pasien Infeksi Saluran Pernapasan Akut. 8(2).

Hamsinah, H., Kosman, R., & Amalia.B, P. (2024). Evaluasi Penggunaan Antibiotik Pada Pasien Infeksi Saluran Pernapasan Atas (Ispa) Di Puskesmas Bima Maroa Kabupaten Konawe Selatan Pada Bulan Januari-September Tahun 2023. Jurnal Kesehatan Tambusai, 5(4), 10742–10751. https://doi.org/10.31004/jkt.v5i4.26992

Hasan, M., & The, F. (2020). Analisis Deskriptif ISPA pada Anak dan Balita di Pulau Moti. 1654(09), 382–389.

IDAI. (2013). Formularium spesialistik ilmu kesehatan anak.

Nabila, S. P., Nasel, F., & Kurniasih, N. (2024). Evaluasi Penggunaan Antibiotik Pada Pasien Infeksi Saluran Pernafasan Akut (ISPA) Bagian Atas di Puskesmas Bogor Selatan. Jurnal Farmapedia (Pharmapedia Journal), 2(1), 22–31.

Novrianti, I. (2023). Profil Penggunaan Obat Pada Pasien Infeksi Saluran Nafas Akut ( ISPA ) Pada Pasien Anak Usia 5-10 Tahun Profile Of The Use Of The Drug In Patients Acute Respiratory Tract Infection In Child Patients Aged 5-10 Years. c, 248–253.

Nurrohmah, A. A. (2025). Sains Medisina. 3(5), 441–448.

Permenkes RI. (2014). Peraturan Menteri Kesehatan Republik Indonesia Nomor 25 Tahun 2014 Tentang upaya kesehatan Anak.

Runtu, A. Y., Tampa’i, R., Sakul, R. V., Untu, S. D., & Karauwan, F. A. (2020). Evaluasi Rasionalitas Penggunaan Antibiotik Pada Pasien ISPA Anak Rawat Inap Di Rumah Sakit Siloam Manado. Biofarmasetikal Tropis, 3(1), 136–142. https://doi.org/10.55724/j.biofar.trop.v3i1.269.

Sari, W. K., Advistasari, Y. D., & Elisa, N. (2024). Pola Peresepaan Antibiotik Untuk Pengobatan Infeksi Saluran Pernapasan Atas (ISPA) Di KLINIK X Kota Semarang. 8(1), 17–27.

Setya Enti Rikomah, Devi Novia, S. R. (2018). Gambaran Penggunaan AntibiotikPada Pasien Pediatri Infeksi Saluran Pernapasan Akut ( ISPA ). 4(1), 28–35.

Supiani Rahayu, Putri Ramdaniah, Depi Yuliana, Ade Sukma Hamdani, F. (2025). Evaluasi Rasionalitas Penggunaan Antibiotik Pada Pasien Anak Diagnosa ISPA Dengan Metode Gyssens di Puskesmas Bagu.

Sutriati Tuloli, T., Ain Thomas, N., Makkulawu, A., Aprianto Paneo, M., & Sanad, W. A. (2024). Tingkat Pengetahuan Pasien Terapi Infeksi Saluran Pernapasan Akut (ISPA) di Puskesmas Kotamobagu. Indonesian Journal of Pharmaceutical Education, 4(2), 246–254. https://doi.org/10.37311/ijpe.v4i2.13341

Syilfia Hasti et al. (2024). Gambaran Penggunaan Obat Antibiotik Pada Pasien ISPA (Infeksi Saluran Pernapasan Akut) di Puskesmas Sidomulyo KOta Pekan Baru. 06(01), 4129–4134.

Wahyuni Usman1, John Taruna 2, N. K. (2020). Faktor Penyebab Kejadian Infeksi Saluran Pernapasan Akut (ISPA) Di Musim Kemarau Pada Wilayah Puskesmas Kampar. 4, 149–156.

Downloads

Published

2026-09-28

Citation Check